Acadian Asset Management’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
405,481
-23,052
| -5% | -$6.82K | ﹤0.01% | 1377 |
|
|
2025
Q1 | $121K | Sell |
428,533
-5,959
| -1% | -$1.68K | ﹤0.01% | 1322 |
|
|
2024
Q4 | $254K | Sell |
434,492
-42,010
| -9% | -$24.6K | ﹤0.01% | 1216 |
|
|
2024
Q3 | $211K | Buy |
476,502
+158,412
| +50% | +$70.1K | ﹤0.01% | 1344 |
|
|
2024
Q2 | $842K | Sell |
318,090
-231,848
| -42% | -$614K | ﹤0.01% | 1052 |
|
|
2024
Q1 | $1.51M | Buy |
549,938
+405,793
| +282% | +$1.11M | 0.01% | 732 |
|
|
2023
Q4 | $348K | Buy |
144,145
+4,603
| +3% | +$11.1K | ﹤0.01% | 1114 |
|
|
2023
Q3 | $281K | Sell |
139,542
-105,277
| -43% | -$212K | ﹤0.01% | 1129 |
|
|
2023
Q2 | $721K | Sell |
244,819
-122,096
| -33% | -$360K | ﹤0.01% | 964 |
|
|
2023
Q1 | $915K | Buy |
366,915
+234,421
| +177% | +$585K | ﹤0.01% | 898 |
|
|
2022
Q4 | $417K | Buy |
+132,494
| New | +$417K | ﹤0.01% | 1092 |
|
|
2022
Q3 | – | Sell |
-14,903
| Closed | -$45K | – | 1667 |
|
|
2022
Q2 | $45K | Buy |
+14,903
| New | +$45K | ﹤0.01% | 1508 |
|